Zachary Brennan / endpoints - China is "eating our lunch" on new drug approvals and clinical trial starts, HHS Secretary Robert F. Kennedy Jr. told Congress Tuesday, while praising the FDA's actions so far. "We are losing scientists, we're losing ...
AI Summary: Robert F. Kennedy Jr. publicly criticized U.S. biotech competitiveness—singling out China as gaining ground—and declined to fully endorse the new CDC vaccine director, blending industry critique with public‑health ambivalence. His comments underscore tensions between political positioning and health policy messaging while rattling stakeholders who prefer facts over theatrical proclamations.
Vanderbilt’s experimental C. diff vaccine shows promising protection / 3 months
Nasal-spray ‘universal’ vaccine protects mice from many respiratory threats / 3 months
AMA launches independent vaccine safety review after CDC criticism / 3 months
World Cancer Day Global Awareness Campaign / 3 months
Gene therapy pioneers win Breakthrough Prize for CRISPR sickle‑cell work / 6 wks
FDA links eight deaths to Amgen’s Tavneos; scrutiny intensifies / 1 month
U.S. flu vaccine showed unusually low effectiveness this season / 2 months
StackHealth RSS

StackHealth Time Machine
NorthFeed Inc. Terms and Conditions / Privacy Policy
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.